- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Inflammatory Bowel Disease Doubles Pregnancy Complications
LONDON -- Inflammatory bowel disease roughly doubles a woman's risk of having a premature or a low-birth-weight child, according to a meta-analysis.
LONDON, Dec. 21-- Inflammatory bowel disease roughly doubles a woman's risk of having a premature or low-birth-weight child, according to a meta-analysis.
Women with IBD should be treated as a potentially high-risk group, said Paris Tekkis, M.D., of St. Mary's Hospital, Imperial College here, and colleagues in an online report in Gut.
With data from a Medline search of studies published from 1980 to 2006, the researchers did a meta-analysis of 12 studies that reported pregnancy and birth outcomes for women with and without IBD.
The analysis of 3,907 patients with IBD included 1,952 (63%) women with Crohn's disease, 1,113 (36%) with ulcerative colitis, and 320,531 controls.
The investigators found that women with IBD had a 1.87-fold increase in the incidence of prematurity (< 37 weeks gestation; 95% CI 1.52 to 2.31; P
FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment
October 14th 2025FDA approves updated indication for upadacitinib in ulcerative colitis and Crohn disease treatment, allowing use after one systemic therapy when TNF blockers are clinically inadvisable.
Clinical Tips for Using Antibiotics and Corticosteroids in IBD
January 5th 2013The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.
